IL100330D0 - Indole derivative and pharmaceutical compositions containing it - Google Patents

Indole derivative and pharmaceutical compositions containing it

Info

Publication number
IL100330D0
IL100330D0 IL10033091A IL10033091A IL100330D0 IL 100330 D0 IL100330 D0 IL 100330D0 IL 10033091 A IL10033091 A IL 10033091A IL 10033091 A IL10033091 A IL 10033091A IL 100330 D0 IL100330 D0 IL 100330D0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
indole derivative
indole
derivative
Prior art date
Application number
IL10033091A
Other versions
IL100330A (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB909026998A priority Critical patent/GB9026998D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL100330D0 publication Critical patent/IL100330D0/en
Publication of IL100330A publication Critical patent/IL100330A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
IL10033091A 1990-12-12 1991-12-11 3-[2(dimethylamino)ethyl]-n-methyl-1h-indole-5-methanesulphonamide sulphate salt (2:1) process for its preparation and pharmaceutical composition containing it IL100330A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB909026998A GB9026998D0 (en) 1990-12-12 1990-12-12 Medicaments

Publications (2)

Publication Number Publication Date
IL100330D0 true IL100330D0 (en) 1992-09-06
IL100330A IL100330A (en) 1996-06-18

Family

ID=10686904

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10033091A IL100330A (en) 1990-12-12 1991-12-11 3-[2(dimethylamino)ethyl]-n-methyl-1h-indole-5-methanesulphonamide sulphate salt (2:1) process for its preparation and pharmaceutical composition containing it

Country Status (35)

Country Link
US (2) US5554639A (en)
EP (1) EP0490689B1 (en)
JP (1) JP2994037B2 (en)
KR (1) KR100211479B1 (en)
CN (2) CN1030890C (en)
AP (1) AP230A (en)
AT (1) AT119881T (en)
AU (1) AU650706B2 (en)
BE (1) BE1005085A3 (en)
CA (1) CA2098302C (en)
CH (1) CH684192A5 (en)
CY (1) CY2005A (en)
CZ (1) CZ281931B6 (en)
DE (2) DE69108200T2 (en)
DK (1) DK0490689T3 (en)
EG (1) EG20219A (en)
ES (1) ES2069836T3 (en)
FR (1) FR2670487B1 (en)
GB (2) GB9026998D0 (en)
GR (1) GR3015430T3 (en)
HK (1) HK82697A (en)
HU (1) HU211937A9 (en)
IE (1) IE62894B1 (en)
IL (1) IL100330A (en)
IS (1) IS1706B (en)
IT (1) IT1252868B (en)
MX (1) MX9102501A (en)
NL (1) NL9102071A (en)
NZ (1) NZ240942A (en)
PT (1) PT99757B (en)
RU (1) RU2108328C1 (en)
TW (2) TW300886B (en)
WO (1) WO1992010477A1 (en)
YU (1) YU48926B (en)
ZA (1) ZA9109750B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0573221T3 (en) * 1992-06-05 1998-10-07 Merck Sharp & Dohme The sulphate salt of a substituted triazole, pharmaceutical compositions thereof and their use in therapy
FR2749846B1 (en) * 1996-06-17 1998-09-11 Pf Medicament Methanesulfonate salt of an aryl piperazine derivative of tryptamine and solvates for pharmaceutical use
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6106837A (en) * 1997-05-15 2000-08-22 Hirsch; Alan R. Method of treating headaches, and article of manufacture therefor
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
GB9926250D0 (en) * 1999-11-06 2000-01-12 Knoll Ag Chemical process
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US6426084B1 (en) * 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
DE60228294D1 (en) * 2001-06-05 2008-09-25 Ronald Aung-Din Topische migränetherapie
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
AU2003303631B2 (en) * 2002-12-26 2008-05-29 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Multilayer Dosage Forms Containing NSAIDs and Triptans
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
WO2005119607A2 (en) * 2004-06-03 2005-12-15 Tyfone, Inc. System and method for securing financial transactions
CA2569964A1 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (en) 2005-05-20 2008-01-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
WO2007137167A2 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
JP2010522135A (en) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ,インコーポレイテッド Pharmaceutical compositions
AU2007310949A1 (en) * 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
US8124126B2 (en) 2008-01-09 2012-02-28 Charleston Laboratories, Inc. Pharmaceutical compositions
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
EA020455B1 (en) 2008-05-27 2014-11-28 Байота Сайентифик Менеджмент Пти Лтд. 6-{2-[l-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLE BIS(DIHYDROGENPHOSPHATE) SALT (1:2), METHOD FOR PRODUCTION THEREOF, AND USE THEREOF IN A COMPOSITION AND METHOD OF TREATING OR PREVENTING PICORNAVIRUS INFECTIONS
WO2009152551A1 (en) * 2008-06-20 2009-12-23 Alphapharm Pty Ltd Pharmaceutical formulation
WO2010008776A2 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8592424B2 (en) * 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP2480197B1 (en) 2009-09-25 2015-11-11 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
AU2016226267A1 (en) 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
CZ281931B6 (en) 1997-04-16
AU650706B2 (en) 1994-06-30
MX9102501A (en) 1992-09-01
YU48926B (en) 2002-12-10
PT99757B (en) 1999-05-31
DE69108200D1 (en) 1995-04-20
IS3790A7 (en) 1992-06-13
GB2251614B (en) 1994-12-14
GR3015430T3 (en) 1995-06-30
US5554639A (en) 1996-09-10
ITRM910922D0 (en) 1991-12-11
CH684192A5 (en) 1994-07-29
HK82697A (en) 1997-06-27
YU191491A (en) 1994-04-05
CA2098302A1 (en) 1992-06-13
JP2994037B2 (en) 1999-12-27
IE62894B1 (en) 1995-03-08
JPH06503560A (en) 1994-04-21
EP0490689A1 (en) 1992-06-17
CZ114093A3 (en) 1994-02-16
BE1005085A3 (en) 1993-04-13
FR2670487B1 (en) 1993-08-20
IT1252868B (en) 1995-06-28
IL100330A (en) 1996-06-18
CA2098302C (en) 2001-10-16
NL9102071A (en) 1992-07-01
AP230A (en) 1993-01-27
CY2005A (en) 1997-12-05
IS1706B (en) 1998-12-10
KR100211479B1 (en) 1999-08-02
TW300886B (en) 1997-03-21
CN1050831C (en) 2000-03-29
GB2251614A (en) 1992-07-15
ZA9109750B (en) 1992-10-28
AU9072091A (en) 1992-07-08
EP0490689B1 (en) 1995-03-15
GB9026998D0 (en) 1991-01-30
AT119881T (en) 1995-04-15
PT99757A (en) 1992-12-31
DE69108200T2 (en) 1995-07-20
CN1030890C (en) 1996-02-07
US5705520A (en) 1998-01-06
NZ240942A (en) 1994-03-25
EG20219A (en) 1997-11-30
HU211937A9 (en) 1996-01-29
TW205035B (en) 1993-05-01
ITRM910922A1 (en) 1992-06-13
AP9100339A0 (en) 1992-01-31
DK0490689T3 (en) 1995-05-22
CN1128259A (en) 1996-08-07
IE914317A1 (en) 1992-06-17
CN1063099A (en) 1992-07-29
RU2108328C1 (en) 1998-04-10
WO1992010477A1 (en) 1992-06-25
ES2069836T3 (en) 1995-05-16
GB9126297D0 (en) 1992-02-12
FR2670487A1 (en) 1992-06-19

Similar Documents

Publication Publication Date Title
AU645867B2 (en) 2-arylthiazole derivative and pharmaceutical composition containing the same
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
HU9303143D0 (en) Pharmaceutical compositions
NZ273617A (en) N-phenyl-2-pyrimidineamine derivatives pharmaceutical compositions
IL99165D0 (en) Heterocyclic compounds and their preparation and pharmaceutical compositions containing them
NZ239425A (en) Sulphonamide derivatives and pharmaceutical compositions
GB9022788D0 (en) Pharmaceutical formulations
ZA9102411B (en) Pharmaceutical formulations
IE64274B1 (en) Pharmaceutical formulations
IL93433A (en) N-substituted indole derivatives their preparation and pharmaceutical compositions containing them
NZ239846A (en) Sulphonamide derivatives and pharmaceutical compositions thereof
HU9601285A3 (en) Substituted n-(indole-2-carbonyl)-beta-alaninamides and derivatives and pharmaceutical compositions containing them
IL116917A (en) Piperidine derivatives and pharmaceutical compositions containing them
ZA9300234B (en) Flavour-masked pharmaceutical compositions
NZ233426A (en) Substituted phenylpyrimidone derivatives and pharmaceutical compositions
NZ270727A (en) Piperidine derivatives and pharmaceutical compositions
IL114759A (en) Benzoxazole derivatives and pharmaceutical compositions containing them
IL103798A (en) Indole derivatives pharmaceutical compositions containing them and intermediates for their preparation
ZA9308825B (en) Pharmaceutical compositions
NZ259880A (en) Diaminopurine-beta-d-ribofuranuronamide derivatives and pharmaceutical compositions
NZ260298A (en) 1h-indol-3-ylacetamide and -thioacetamide derivatives and pharmaceutical compositions
NZ261593A (en) 3-piperazinylmethly-1h-indolopyridine derivatives and pharmaceutical compositions
IL111314D0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
NZ248762A (en) Azaquinoxaline derivatives; preparation and pharmaceutical compositions
GB9212511D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patents granted
KB Patents renewed
KB Patents renewed
KB Patents renewed
EXTP Application for extension orders is pending
PEL Intension of commissioner to extend period of protection
MM9K Patent not in force due to non-payment of renewal fees